FindTrial
Sign In

The analysis of course and prognostic factors of COVID-19 in Shanghai from April to June 2022——Clinical Cohort Study of Real Life

The analysis of course and prognostic factors of COVID-19 in Shanghai from April to June 2022——Clinical Cohort Study of Real Life

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060003
Enrollment
Unknown
Registered
2022-05-14
Start date
2022-05-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

case series:None

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older; 2. Patients diagnosed with COVID-19 infection who admitted to Shanghai Geriatric Center and designated hospitals in Minhang District from May 2022 to July 2022; 3. The COVID-19 diagnosis referred to COVID-19 Diagnosis and Treatment Protocol (Trial Ninth Edition); 4. Patients or family members agree to participate and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating subjects; 2. Subjects with mental illness; 3. The investigator judged those who could not complete the study.

Design outcomes

Primary

MeasureTime frame
all-cause mortality;—

Secondary

MeasureTime frame
length of stay in hospital;clinical type;rate of intensive care unit admission;number of endotracheal intubation;—

Countries

China

Contacts

Public ContactSong Zhenju

Zhongshan Hospital, Fudan University

song.zhenju@zs-hospital.sh.cn+86 13816607453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026